Health Trials

Primary Immunodeficiency Diseases (PID)

4

Review clinical trials related to Primary Immunodeficiency Diseases (PID). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency

This study is a retrospective database study in Japan to evaluate the safety of Immune Globulin Subcutaneous (Human), 20% Solution in participants with primary immunodeficiency disease (PID). This survey will conduct in use of medical database called PIDJ2.

Participants needed: 100
Trial details
Biological sex: AllType: ObservationalSponsor: TakedaUpdated: Feb 20, 2026Locations: 1
Eligibility criteria

Patients with primary immunodeficiency (PID) enrolled in the PID patient registr... [+3]

Participant for whom study drug has not been entered in the drug name in the med... [+2]

Read more
Status: Recruiting

Ex Vivo Evaluation of JAK-inhibitor and Gene Therapeutical Approach in JAK-STAT Related Disorders

The investigators want to study the JAK-inhibitors and their impact on the immune system and evaluate the potential of a gene-therapeutic strategy

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: prof. dr. Rik SchrijversUpdated: Dec 3, 2025Locations: 1
Eligibility criteria

Cases (A): adult patients presenting with a genetically confirmed or highly susp... [+1]

Children (< 18 years at time of recruitment) [+1]

Read more
Status: Not yet recruiting

Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients

The study duration for individual patients will be up to 55 weeks for the 4-weekly and 3- weekly schedule of the treatment which includes 3 weeks for screening, 48 weeks for Study Medication administration and 4 weeks for follow-up assessments

Participants needed: 44
Trial details
Phase: Phase 3Age: 2-65Biological sex: AllType: InterventionalSponsor: Virchow GroupUpdated: Jun 12, 2025Locations: 2
Eligibility criteria

Male or female, aged 2 to 65 years. [+11]

Pregnant women, nursing mothers or a planned pregnancy within 18 months of parti... [+15]

Read more
Status: Not yet recruiting

Inbon Errors of Immunity Attending Assiut University Children&Amp;#39;s Hospital: a Single Center Study

Aim of Study The aim of this study to describe the clinical profile of children diagnosed as IEIs who were admitted to in Assiut university children\&amp;#39;s Hospital.

Participants needed: 60
Trial details
Age: Up to 18Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Oct 21, 2024
Eligibility criteria

patients without any criteria of ten warning signs

Read more